Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas

Abstract

The novel coronavirus, SARS-CoV-2, rapidly spread worldwide, causing an ongoing global pandemic. While the respiratory system is the most common site of infection, a significant number of reported cases indicate gastrointestinal (GI) involvement. GI symptoms include anorexia, abdominal pain, nausea, vomiting, and diarrhea. Although the mechanisms of GI pathogenesis are still being examined, viral components isolated from stool samples of infected patients suggest a potential fecal–oral transmission route. In addition, viral RNA has been detected in blood samples of infected patients, making hematologic dissemination of the virus a proposed route for GI involvement. Angiotensin-converting enzyme 2 (ACE2) receptors serve as the cellular entry mechanism for the virus, and these receptors are particularly abundant throughout the GI tract, making the intestine, liver, and pancreas potential extrapulmonary sites for infection and reservoirs sites for developing mutations and new variants that contribute to the uncontrolled spread of the disease and resistance to treatments. This transmission mechanism and the dysregulation of the immune system play a significant role in the profound inflammatory and coagulative cascades that contribute to the increased severity and risk of death in several COVID-19 patients. This article reviews various potential mechanisms of gastrointestinal, liver, and pancreatic injury.

Black pleural effusion caused by a pancreaticopleural fistula secondary to chronic alcoholic pancreatitis exacerbation accompanying COVID‐19

“… 2 COVID‐19 may have also induced pancreatic damage through systemic inflammatory responses, vasculitis, and thrombosis secondary to SARS‐CoV‐2 infection. 2 During the COVID‐19 pandemic, a significant increase in alcohol consumption has been reported with an accompanying increase in the admission rates and mortality in patients with alcoholic pancreatitis. 3 …”

Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID- 19), which has millions of confirmed cases worldwide. SARS-CoV-2 infection can affect the respiratory tract and other organ systems, resulting in various multi-organ complications [1][2][3].…”

Experimental Lung Inflammation Induced by Inactivated SARS-CoV-2 is Controlled by Intranasal Instillation of Vitamin D

“…A plethora of factors related to the host, the environment, and the virus itself can affect disease outcome [1]. Even though the lung is considered the primary target of this infection, the virus can spread to many other organs as kidneys, intestine, liver, pancreas, spleen, muscles, and the nervous system [2,3]. Pulmonary manifestations vary from asymptomatic or mild pneumonia to a severe disease accompanied by hypoxia, shock, respiratory failure, and multiorgan deterioration or death [4].…”